H. Lundbeck A/S, the Danish specialist in brain diseases, reported a 5% increase in first half year revenue to DKK 7.5 billion (€1.01 billion), powered by a 33% increase of sales in the US. The company also secured an operating profit, after a large loss the previous year from a write-off.
